![Paul Foster](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Paul Foster
Keine laufenden Positionen mehr
Karriereverlauf von Paul Foster
Ehemalige bekannte Positionen von Paul Foster
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Healthgain Solutions Ltd. | Corporate Officer/Principal | - | - |
Genzyme Ltd. (United Kingdom)
![]() Genzyme Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Ltd. is a healthcare organization based in Haverhill, UK. Genzyme Ltd. is involved in research and development, transforming scientific innovation into healthcare solutions for people nationwide and across the globe. The British company witnesses the miracles of science when hard work results in new, cutting-edge medicines, services, and devices. Founded in 1981, the company works with the NHS and the pharmaceutical industry to deliver patient-centered initiatives, including joint working projects. | Corporate Officer/Principal | - | - |
Oxagen Ltd.
![]() Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Verwaltungsdirektor | 01.08.2004 | 15.09.2009 |
Finanzdirektor/CFO | 01.08.2004 | - |
Statistik
International
Vereinigtes Königreich | 4 |
Operativ
Corporate Officer/Principal | 2 |
Chief Administrative Officer | 1 |
Director of Finance/CFO | 1 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 3 |
---|---|
Oxagen Ltd.
![]() Oxagen Ltd. Pharmaceuticals: MajorHealth Technology Oxagen Ltd. develops novel molecule drugs to treat inflammatory and respiratory diseases. It offers OC000459, an oral CRTH2 antagonist for the treatment of eosinophilic asthma and allergic rhino conjunctivitis. The company was founded by Nick Cross, John Irving Bellin, Mark Edwards, Trevor J. Nicholls and Ian Michael Laing on September 05 1996 and is headquartered in London, the United Kingdom. | Health Technology |
Healthgain Solutions Ltd. | |
Genzyme Ltd. (United Kingdom)
![]() Genzyme Ltd. (United Kingdom) Pharmaceuticals: MajorHealth Technology Part of Sanofi, Genzyme Ltd. is a healthcare organization based in Haverhill, UK. Genzyme Ltd. is involved in research and development, transforming scientific innovation into healthcare solutions for people nationwide and across the globe. The British company witnesses the miracles of science when hard work results in new, cutting-edge medicines, services, and devices. Founded in 1981, the company works with the NHS and the pharmaceutical industry to deliver patient-centered initiatives, including joint working projects. | Health Technology |
- Börse
- Insiders
- Paul Foster
- Erfahrung